CDC Surveillance System: CKD Stages Among U.S. Adults by Year. https://nccd.cdc.gov/ckd/detail.aspx?Qnum=Q372#refreshPosition. Accessed 20 Mar 2023.

CDC Surveillance System: Trends in Prevalence of CKD Among U.S. Adults. https://nccd.cdc.gov/ckd/detail.aspx?Qnum=Q9&topic=1#refreshPosition. Accessed 11 June 2025.

Heron JE, Bagnis CI, Gracey DM. Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV. AIDS Res Ther. 2020;17(1):11. https://doi.org/10.1186/s12981-020-00266-3.

Article  PubMed  PubMed Central  Google Scholar 

Lucas GM, Ross MJ, Stock PG, et al. Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV medicine association of the infectious diseases society of America. Clin Infect Dis. 2014;59(9):e96–138. https://doi.org/10.1093/cid/ciu617.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wearne N, Davidson B, Blockman M, Swart A, Jones ES. HIV, drugs and the kidney. Drugs Context. 2020;9:1–17. https://doi.org/10.7573/dic.2019-11-1.

Article  Google Scholar 

Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67(6):2089–100. https://doi.org/10.1111/j.1523-1755.2005.00365.x.

Article  PubMed  Google Scholar 

GFR. National Kidney Foundation. 2014. https://www.kidney.org/kidneydisease/siemens_hcp_gfr. Accessed 7 Jan 2023.

Carrara F, Gaspari F. GFR measured by iohexol: the best choice from a laboratory perspective. J Lab Precis Med. 2018;3:77–77. https://doi.org/10.21037/jlpm.2018.09.07.

Article  Google Scholar 

Bjornstad P, Karger AB, Maahs DM. Measured GFR in routine clinical Practice—The promise of dried blood spots. Adv Chronic Kidney Dis. 2018;25(1):76–83. https://doi.org/10.1053/j.ackd.2017.09.003.

Article  PubMed  PubMed Central  Google Scholar 

Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C–Based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–49. https://doi.org/10.1056/NEJMoa2102953.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Delgado C, Baweja M, Crews DC, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease. J Am Soc Nephrol. 2021;32(12):2994–3015. https://doi.org/10.1681/ASN.2021070988.

Article  CAS  PubMed  PubMed Central  Google Scholar 

NKF KDOQI Guidelines. Accessed 7 Jan 2023. http://kidneyfoundation.cachefly.net/professionals/KDOQI/guidelines_ckd/p4_class_g1.htm

Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med. 1988;39(1):465–90. https://doi.org/10.1146/annurev.me.39.020188.002341.

Article  CAS  PubMed  Google Scholar 

Garimella PS, Tighiouart H, Sarnak MJ, Levey AS, Ix JH. Tubular secretion of creatinine and risk of kidney failure: the modification of diet in renal disease (MDRD) study. Am J Kidney Dis Off J Natl Kidney Found. 2021;77(6):992–4. https://doi.org/10.1053/j.ajkd.2020.09.017.

Article  CAS  Google Scholar 

Gottlieb ER, Estiverne C, Tolan NV, Melanson SEF, Mendu ML. Estimated GFR with Cystatin C and creatinine in clinical practice: A retrospective cohort study. Kidney Med. 2023;5(3):100600. https://doi.org/10.1016/j.xkme.2023.100600.

Article  PubMed  PubMed Central  Google Scholar 

Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum Cystatin C levels. Kidney Int. 2009;75(6):652–60. https://doi.org/10.1038/ki.2008.638.

Article  CAS  PubMed  Google Scholar 

Gupta S, Kitch D, Tierney C, et al. Markers of renal disease and function are associated with systemic inflammation in HIV infection: renal and inflammatory markers in HIV infection. HIV Med. 2015;16(10):591–8. https://doi.org/10.1111/hiv.12268.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chew JSC, Saleem M, Florkowski CM, George PM. Cystatin C–a paradigm of evidence based laboratory medicine. Clin Biochem Rev. 2008;29(2):47–62.

PubMed  PubMed Central  Google Scholar 

Onopiuk A, Tokarzewicz A, Gorodkiewicz E. Cystatin C. Advances in clinical chemistry. Vol. 68. Elsevier; 2015. pp. 57–69. https://doi.org/10.1016/bs.acc.2014.11.007

Tangri N, Stevens LA, Schmid CH, et al. Changes in dietary protein intake has no effect on serum Cystatin C levels independent of the glomerular filtration rate. Kidney Int. 2011;79(4):471–7. https://doi.org/10.1038/ki.2010.431.

Article  CAS  PubMed  Google Scholar 

Hsu Cyuan, Yang W, Parikh RV, et al. Race, genetic Ancestry, and estimating kidney function in CKD. N Engl J Med. 2021;385(19):1750–60. https://doi.org/10.1056/NEJMoa2103753.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pottel H, Björk J, Rule AD, et al. Cystatin C–Based equation to estimate GFR without the inclusion of race and sex. N Engl J Med. 2023;388(4):333–43. https://doi.org/10.1056/NEJMoa2203769.

Article  CAS  PubMed  Google Scholar 

Stevens PE, Ahmed SB, Carrero JJ, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4):S117–314. https://doi.org/10.1016/j.kint.2023.10.018.

Article  Google Scholar 

Newman DJ, Thakkar H, Edwards RG, et al. Serum Cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 1995;47(1):312–8. https://doi.org/10.1038/ki.1995.40.

Article  CAS  PubMed  Google Scholar 

Estimating Glomerular Filtration Rate | NIDDK. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-management/kidney-disease/laboratory-evaluation/glomerular-filtration-rate/estimating. Accessed 7 Jan 2023.

Milburn J, Jones R, Levy JB. Renal effects of novel antiretroviral drugs. Nephrol Dial Transplant Published Online April. 2016;15:gfw064. https://doi.org/10.1093/ndt/gfw064.

Article  CAS  Google Scholar 

Maggi P, Montinaro V, Mussini C, et al. Novel antiretroviral drugs and renal function monitoring of HIV patients. AIDS Rev. 2014;16(3):144–51.

PubMed  Google Scholar 

Palich R, Tubiana R, Abdi B, et al. Plasma Cystatin C as a marker for estimated glomerular filtration rate assessment in HIV-1-infected patients treated with dolutegravir-based ART. J Antimicrob Chemother. 2018;73(7):1935–9. https://doi.org/10.1093/jac/dky112.

Article  CAS  PubMed  Google Scholar 

Yoshino Y, Koga I, Seo K, Kitazawa T, Ota Y. Short communication: the clinical value of Cystatin C as a marker of renal function in HIV patients receiving dolutegravir. AIDS Res Hum Retroviruses. 2017;33(11):1080–2. https://doi.org/10.1089/AID.2017.0074.

Article  CAS  PubMed  Google Scholar 

Cohen SD, Kopp JB, Kimmel PL. Kidney Diseases associated with human immunodeficiency virus infection. N Engl J Med. 2017;377(24):2363–74. https://doi.org/10.1056/NEJMra1508467

Longenecker CT, Kitch D, Sax PE, et al. Reductions in plasma Cystatin C after initiation of antiretroviral therapy are associated with reductions in inflammation: ACTG A5224s. J Acquir Immune Defic Syndr 1999. 2015;69(2):168–77. https://doi.org/10.1097/QAI.0000000000000557.

Article  CAS  Google Scholar 

Jaroszewicz J, Wiercinska-Drapalo A, Lapinski TW, Prokopowicz D, Rogalska M, Parfieniuk A. Does HAART improve renal function? An association between serum Cystatin C Concentration, HIV viral load and Haart duration. Antivir Ther. 2006;11(5):641–6. https://doi.org/10.1177/135965350601100502.

Article  PubMed  Google Scholar 

Mauss S, Berger F, Kuschak D, et al. Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients. Antivir Ther. 2008;13(8):1091–5.

Article  PubMed  Google Scholar 

Overton ET, Patel P, Mondy K, et al. Cystatin C and baseline renal function among HIV-Infected persons in the SUN study. AIDS Res Hum Retroviruses. 2012;28(2):148–55. https://doi.org/10.1089/aid.2011.0018.

Article  CAS  PubMed  Google Scholar 

Hanser S, Choshi J, Mokoena H, et al. A systematic review assessing the potential use of Cystatin c as a biomarker for kidney disease in people living with HIV on antiretroviral therapy. Front Med. 2024;11:1295217. https://doi.org/10.3389/fmed.2024.1295217.